1113 related articles for article (PubMed ID: 30903349)
1. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
2. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
3. Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.
Hargrove TY; Wawrzak Z; Liu J; Nes WD; Waterman MR; Lepesheva GI
J Biol Chem; 2011 Jul; 286(30):26838-48. PubMed ID: 21632531
[TBL] [Abstract][Full Text] [Related]
4. In vitro antiprotozoal activity and cytotoxicity of extracts and fractions from the leaves, root bark and stem bark of Isolona hexaloba.
Musuyu Muganza D; Fruth BI; Nzunzu Lami J; Cos P; Cimanga Kanyanga R; Maes L; Pieters L
J Ethnopharmacol; 2015 Nov; 174():187-94. PubMed ID: 26239153
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
[TBL] [Abstract][Full Text] [Related]
6. Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
Di Pietro O; Vicente-García E; Taylor MC; Berenguer D; Viayna E; Lanzoni A; Sola I; Sayago H; Riera C; Fisa R; Clos MV; Pérez B; Kelly JM; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2015 Nov; 105():120-37. PubMed ID: 26479031
[TBL] [Abstract][Full Text] [Related]
7. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease.
Abdel-Sattar E; Maes L; Salama MM
Phytother Res; 2010 Sep; 24(9):1322-8. PubMed ID: 20127723
[TBL] [Abstract][Full Text] [Related]
9. Novel quinoline derivatives with broad-spectrum antiprotozoal activities.
Hartman CB; Dube PS; Legoabe LJ; Van Pelt N; Matheeussen A; Caljon G; Beteck RM
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300319. PubMed ID: 38396284
[TBL] [Abstract][Full Text] [Related]
10. In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51.
De Vita D; Moraca F; Zamperini C; Pandolfi F; Di Santo R; Matheeussen A; Maes L; Tortorella S; Scipione L
Eur J Med Chem; 2016 May; 113():28-33. PubMed ID: 26922226
[TBL] [Abstract][Full Text] [Related]
11. 1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.0(4,9)]tetradecane and derivatives with in vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum.
Howarth J; Wilson D
Bioorg Med Chem Lett; 2003 Jun; 13(12):2013-5. PubMed ID: 12781185
[TBL] [Abstract][Full Text] [Related]
12. New antiprotozoal agents: their synthesis and biological evaluations.
Upadhayaya RS; Dixit SS; Földesi A; Chattopadhyaya J
Bioorg Med Chem Lett; 2013 May; 23(9):2750-8. PubMed ID: 23518280
[TBL] [Abstract][Full Text] [Related]
13. Antiprotozoal screening and cytotoxicity of extracts and fractions from the leaves, stem bark and root bark of Alstonia congensis.
Lumpu SL; Kikueta CM; Tshodi ME; Mbenza AP; Kambu OK; Mbamu BM; Cos P; Maes L; Apers S; Pieters L; Cimanga RK
J Ethnopharmacol; 2013 Jul; 148(2):724-7. PubMed ID: 23612422
[TBL] [Abstract][Full Text] [Related]
14. Sterol 14α-Demethylase from Trypanosomatidae Parasites as a Promising Target for Designing New Antiparasitic Agents.
da Silva Santos-Júnior PF; Schmitt M; de Araújo-Júnior JX; da Silva-Júnior EF
Curr Top Med Chem; 2021; 21(21):1900-1921. PubMed ID: 33655860
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
[TBL] [Abstract][Full Text] [Related]
17. Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.
Lepesheva GI; Ott RD; Hargrove TY; Kleshchenko YY; Schuster I; Nes WD; Hill GC; Villalta F; Waterman MR
Chem Biol; 2007 Nov; 14(11):1283-93. PubMed ID: 18022567
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of imidazo[1,2-a]pyridine-chalcone conjugates as antikinetoplastid agents.
Agarwal DS; Beteck RM; Ilbeigi K; Caljon G; Legoabe LJ
Chem Biol Drug Des; 2024 Jan; 103(1):e14400. PubMed ID: 37994272
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of tropane halogenated-derivatives against malaria, sleeping sickness, Chagas disease and leishmaniasis.
Cretton S; Bartholomeusz TA; Mehl F; Allenbach Y; Matheeussen A; Cos P; Maes L; Christen P
Med Chem; 2014; 10(8):753-8. PubMed ID: 24813684
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
